Century Therapeutics, Inc.IPSCNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank96
3Y CAGR+36.5%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+36.5%/yr
Quarterly compound
Percentile
P96
Near historical high
vs 3Y Ago
2.5x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 36.41% |
| Q3 2025 | 7.63% |
| Q2 2025 | 19.39% |
| Q1 2025 | -42.03% |
| Q4 2024 | 11.45% |
| Q3 2024 | 0.25% |
| Q2 2024 | 10.36% |
| Q1 2024 | -13.15% |
| Q4 2023 | -60.87% |
| Q3 2023 | 28.78% |
| Q2 2023 | 30.58% |
| Q1 2023 | -17.26% |
| Q4 2022 | 14.32% |
| Q3 2022 | 5.45% |
| Q2 2022 | -143.55% |
| Q1 2022 | 301.32% |
| Q4 2021 | -3.41% |
| Q3 2021 | -36.41% |
| Q2 2021 | -21.01% |
| Q1 2021 | -59.10% |
| Q4 2020 | -10.14% |
| Q3 2020 | -8.49% |
| Q2 2020 | -32.07% |
| Q1 2020 | 0.00% |